IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19

Carole Giraud; Agnès Tran; Elisabeth Rey; Jean Louis Vincent; Jean‐Marc Tréluyer; Gérard Pons

doi:10.1124/dmd.32.11.1279

Related publications

Article2006

IN VITRO AND IN VIVO INHIBITORY EFFECT OF STIRIPENTOL ON CLOBAZAM METABOLISM

Carole Giraud, Jean‐Marc Tréluyer, Elisabeth Rey, Catherine Chiron, Jean Louis Vincent, Gérard Pons, Agnès Tran

Article1999

INDUCTION OF NAPH CYTOCHROME P450 REDUCTASE BY AMYLOID β PROTEIN

Miguel A. Pappolla, Y-J. Chvan, Peter Bozner, Burkhard Pöeggeler, B Frangione, Karen Hsiao, R. A. Omai, George Perry, M. A. L. Smith, Jorge Ghiso

Article2013

Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset

Allan Gordon, Holly K. Tabor, Andrew D. Johnson, Beverly M. Snively, Themistocles L. Assimes, P. L. Auer, John P A Ioannidis, Ulrike Peters, Jennifer G. Robinson, Lara E. Sucheston, Daqing Wang, N Sotoodehnia, Jerome I. Rotter, Bruce M. Psaty, Rebecca D. Jackson, David M. Herrington, Chris O’Donnell, Alex P. Reiner, Stephen S. Rich, Mark J. Rieder, Michael J. Bamshad, Deborah A. Nickerson

Article2005

Inhibitory effect of stiripentol on clobazam metabolism by cDNA-expressed human CYP

A. Tran, C Giraud, Elisabeth Rey, Jean Louis Vincent, Jean‐Marc Tréluyer, Gérard Pons

Article2015

Piezotronic-Effect Enhanced Drug Metabolism and Sensing on a Single ZnO Nanowire Surface with the Presence of Human Cytochrome P450

Ning Wang, Caizhen Gao, Fei Xue, Yu Han, Tao Li, Xia Cao, Xueji Zhang, Yue Zhang, Zhong Lin Wang